Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study.
Corazzelli G, Cuccaro A, Morelli E, Arcamone M, De Chiara A, Paccone A, Petrillo A, Ibello F, Aversa C, Esposito M, Volzone F, Saggese M, Capobianco G, Sarno S, Sirica L, Crisci S, De Filippi R, Pinto A. Corazzelli G, et al. Among authors: sarno s. Br J Haematol. 2024 Oct;205(4):1383-1388. doi: 10.1111/bjh.19646. Epub 2024 Aug 1. Br J Haematol. 2024. PMID: 39091109 Clinical Trial.
Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology.
Crisci S, Amitrano F, Saggese M, Muto T, Sarno S, Mele S, Vitale P, Ronga G, Berretta M, Di Francia R. Crisci S, et al. Among authors: sarno s. Medicina (Kaunas). 2019 Jul 28;55(8):414. doi: 10.3390/medicina55080414. Medicina (Kaunas). 2019. PMID: 31357735 Free PMC article. Review.
Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment.
Volzone F, Becchimanzi C, Crisci S, De Chiara A, Porto A, Caronna A, Cuccaro A, Sarno S, Mallardo D, Cagini L, De Filippi R, Pinto A. Volzone F, et al. Among authors: sarno s. Ann Hematol. 2024 Nov;103(11):4759-4764. doi: 10.1007/s00277-024-05994-4. Epub 2024 Sep 12. Ann Hematol. 2024. PMID: 39264432
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells.
Minopoli M, Sarno S, Cannella L, Tafuto S, Scognamiglio G, Gallo M, Fazioli F, Azzaro R, Apice G, De Angelis B, Tamborini E, Garofalo C, Pignochino Y, Mercatali L, Ibrahim T, Falcioni R, Valenti B, Maestro R, Scotlandi K, De Chiara A, Carriero MV. Minopoli M, et al. Among authors: sarno s. Cancers (Basel). 2021 Jun 30;13(13):3298. doi: 10.3390/cancers13133298. Cancers (Basel). 2021. PMID: 34209309 Free PMC article.
Morphological and pathological features of basal-like breast cancer.
Botti G, Cantile M, Collina F, Cerrone M, Sarno S, Anniciello A, Di Bonito M. Botti G, et al. Among authors: sarno s. Transl Cancer Res. 2019 Oct;8(Suppl 5):S503-S509. doi: 10.21037/tcr.2019.06.50. Transl Cancer Res. 2019. PMID: 35117128 Free PMC article. Review.
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
Minopoli M, Botti G, Gigantino V, Ragone C, Sarno S, Motti ML, Scognamiglio G, Greggi S, Scaffa C, Roca MS, Stoppelli MP, Ciliberto G, Losito NS, Carriero MV. Minopoli M, et al. Among authors: sarno s. J Exp Clin Cancer Res. 2019 Nov 8;38(1):459. doi: 10.1186/s13046-019-1465-8. J Exp Clin Cancer Res. 2019. PMID: 31703596 Free PMC article.
171 results